MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: dystonia"

  • 2016 International Congress

    Assessing vestibular function in individuals with cervical dystonia and the effects of botulinum toxin treatment

    K.L. Andrzejewski, A. Owens, M.T. Bull, K.M. Biglan, S. Kanchana, J.W. Mink, R. Barbano (Rochester, NY, USA)

    Objective: To determine if individuals with cervical dystonia have altered vestibular function compared to unaffected individuals, and whether botulinum toxin treatment alters those variables. Background:…
  • 2016 International Congress

    Clinical profile of patients with writer’s cramp

    H.S. Kaleagasi, O. Dogu (Mersin, Turkey)

    Objective: To present the clinical profile of 16 patients with simple writer's cramp who were treated with botulinum toxin injections. Background: Writer's cramp is the…
  • 2016 International Congress

    Epidemiological and clinical profile of essential blepharospasm and its response to treatment with TBA over a 11-year period

    J.R.R. Manoel, U.C. Júnior, D.P. Nones, F.M.B. Germiniani, H.A.G. Teive (Curitiba, Brazil)

    Objective: To report the epidemiological and clinical profile of patients with essential bleaphrospasm from the outpatient clinic of Movement Disorders of the Hospital de Clínicas…
  • 2016 International Congress

    Synergistic effects of physical therapy and botulinum toxin in primary cervical dystonia

    W. Hu, V. Rundle-Gonzalez, S.J. Kulkarni, L. Almeida, M. Okun, A. Wagle Shukla (Gainesville, FL, USA)

    Objective: To compare standard botulinum toxin (BoNT) versus physical therapy (PT) combined with BoNT in primary cervical dystonia (PCD). Background: PCD is frequently a source…
  • 2016 International Congress

    Pilot study on the long lasting effectivness of an integrated tailored sensory-motor rehabilitation program associated with BoNTA in cervical dystonia

    A. Castagna, M. Ramella, A. Crippa, L. Sciumè, G. Giacobbi, C. Corrini, D. Anastasi, A. Montesano (Milano, Italy)

    Objective: The aim of this study is to assess the long lasting effectiveness of an integrated tailored sensory-motor rehabilitation program (TsmRP) associated with botulinum toxin…
  • 2016 International Congress

    Does GPi-DBS help non motor symptoms in cervical dystonia patients? A retrospective study of 17 patients

    L. Lowry, B. Hammersley, M. Bonello, P. Byrne, N.A. Fletcher, J.O. Farah, P.R. Eldridge, S.H. Alusi (Liverpool, United Kingdom)

    Objective: To study the efficacy of GPi DBS surgery in improving dystonia related severity, disability and pain as well as quality of life in medically…
  • 2016 International Congress

    Structural and connectivity changes after botulinum neurotoxin therapy in blepharospasmus and hemifacial spasm

    C.V. Chirumamilla, G. Deuschl, K.E. Zeuner, M. Muthuraman, S. Groppa (Mainz, Germany)

    Objective: The two primary objectives of this study were to investigate the structural grey matter changes and connectivity differences between patients with BEB and HFS…
  • 2016 International Congress

    Quality of life and epidemiological profile of patients undergoing botulinum toxin treatment

    G. Amorelli, L.F. Vasconcellos, M. Spitz, L.F. Fraga (Rio de Janeiro, Brazil)

    Objective: To trace a clinical and epidemiological profile of patients treated with botulinum toxin, evaluating the impact on quality of life. Background: The Botulinum Toxin…
  • 2016 International Congress

    Assessment of need for treatment with botulinum toxin type A in cervical dystonia patients

    C.L. Vaughan, G.T. Stebbins, C.L. Comella (Charleston, SC, USA)

    Objective: To prospectively assess the interval in weeks between injection of botulinum toxin A (BoNTA) and patient-perceived need for the next injection for treatment of…
  • 2016 International Congress

    Evaluation of stigmatization and quality of life before and after botulinum toxin treatment in hemifacial spasm

    B. Yuksel, F. Genc, A. Yaman, P. Dogan Ak, E. Ozaydin Goksu, A. Aybar, Y. Bicer Gomceli (Antalya, Turkey)

    Objective: Hemifacial spasm (HFS) is a chronic disease that is characterized by involuntary tonic and clonic contractions of the muscles innervated by the ipsilateral facial…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley